ストックスクリーナーアプリを入手
0.66
1.69%
0.011
前日終値:
$0.649
開ける：
$0.6389
24時間の取引高:
490.37K
Relative Volume:
0.33
時価総額：
$45.34M
収益：
$3.67M
当期純損益:
$-13.83M
株価収益率:
-2.3571
EPS:
-0.28
ネットキャッシュフロー:
$-10.79M
1週間 パフォーマンス:
-7.41%
1か月 パフォーマンス:
-20.80%
6か月 パフォーマンス:
-35.92%
1年 パフォーマンス:
+10.29%
1日の値動き範囲:
$0.59
$0.6856
1週間の範囲:
$0.59
$0.75
52週間の値動き範囲:
$0.59
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
ICCM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.66 | 44.75M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Icecure Medical Ltd (ICCM) 最新ニュース
IceCure Medical Ltd (NASDAQ:ICCM) Q3 2025 Earnings Call Transcript - Insider Monkey
How IceCure Medical Ltd stock compares to market leadersJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Is IceCure Medical Ltd stock a bargain at current levels2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
IceCure Medical Reports Q3 2025 Financial Results - TipRanks
Is IceCure Medical Ltd a candidate for recovery playJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
IceCure Medical Ltd stock momentum explained2025 Year in Review & Verified Stock Trade Ideas - newser.com
Using Ichimoku Cloud for IceCure Medical Ltd technicals - newser.com
IceCure Medical’s Earnings Call Highlights Growth Potential - TipRanks
ICCM: FDA approval of ProSense drives growth prospects amid revenue decline and strong cash position - TradingView
Does IceCure Medical Ltd fit your quant trading modelJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
IceCure Medical Q3 2025 Earnings Call Transcript - MarketBeat
IceCure Medical Gains FDA Approval for ProSense® in Breast Cancer Treatment - MSN
IceCure Medical Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025 - MarketScreener
IceCure Medical Ltd. (ICCM) Q3 FY2025 earnings call transcript - Yahoo Finance
ICCM: FDA approval for ProSense® sets stage for accelerated growth despite lower 2025 revenue - TradingView
When is the best time to exit IceCure Medical LtdTrade Analysis Report & Fast Gain Stock Trading Tips - newser.com
Press Release: IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 - 富途牛牛
IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 - Yahoo Finance
IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 - Finviz
IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer - The Malaysian Reserve
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
IceCure's ProSense® cryoablation system receives regulatory approval in Switzerland for indications including breast, lung, liver, and kidney cancer - MarketScreener
IceCure (NASDAQ: ICCM) receives Swissmedic approval for ProSense in breast and lung cancer - Stock Titan
IceCure Medical receives Nasdaq minimum bid price notification - Medical Buyer
Why IceCure Medical Ltd stock attracts high net worth investors2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Market reaction to IceCure Medical Ltd’s recent newsRecession Risk & Scalable Portfolio Growth Ideas - newser.com
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price No - GuruFocus
IceCure Medical Receives Nasdaq Bid Price Notification - TipRanks
IceCure Medical announces receipt of Nasdaq minimum bid price notification - MarketScreener
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification - Barchart.com
Can swing trading help recover from IceCure Medical Ltd lossesJuly 2025 Review & Technical Buy Zone Confirmation - newser.com
IceCure Medical to Report Third Quarter 2025 Financial and Opera - GuruFocus
IceCure Medical (NASDAQ: ICCM) sets Nov 19 results call at 10:00 a.m. EST - Stock Titan
Can IceCure Medical Ltd rally from current levelsEarnings Trend Report & AI Enhanced Trading Alerts - newser.com
IceCure Promotes Shay Levav to Chief Operating Officer - citybiz
IceCure Medical (ICCM) Appoints Shay Levav as COO to Boost Growt - GuruFocus
Will IceCure Medical Ltd stock deliver shareholder valueMarket Growth Summary & Capital Protection Trading Alerts - newser.com
IceCure (NASDAQ: ICCM) names Levav COO after FDA marketing authorization for ProSense - Stock Titan
IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction - Yahoo Finance
What moving averages say about IceCure Medical LtdJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Comparing IceCure Medical Ltd in custom built stock radarsTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Icecure Medical Ltd (ICCM) 財務データ
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):